FDA Recalls MACA Gold Tablets Containing Unapproved Sildenafil
A&H Focal Inc. is recalling MACA gold tablets sold in New York and New Jersey because they contain sildenafil, an unapproved drug.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class I recall, which mandates a severity score of at least 4 per the rubric.
Plain-English summary
A&H Focal Inc. is recalling MACA gold tablets, 6800 mg, 10-count bottles, which have labeling in a foreign language. The products were distributed in New York and New Jersey through six retail stores named "Asian Food Markets." All lots are affected.
The FDA determined that these products contain sildenafil, a drug approved by the FDA for the treatment of erectile dysfunction. Because the products were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), they are considered unapproved drugs for which safety and efficacy have not been established.
Consumers who purchased these products should stop using them and return them to the place of purchase.
The recalled product
- Product
- MACA gold tablets, 6800 mg, 10-count bottle, labeling is in foreign language
- Manufacturer
- A&H Focal Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Part of a larger recall action
This product is one of 21 recalled by A&H Focal Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 21 products in this recall →Related recalls
Same manufacturer · A&H Focal Inc.
See all →- SevereFDA Recalls Unapproved Miraculous Evil Root Capsules Containing Sildenafil
FDA (Drugs) · 2018-02-07
- SevereFDA Recalls Unapproved Gold Vigra Capsules Containing Sildenafil
FDA (Drugs) · 2018-02-07
- SevereFDA Recalls Unapproved Power V8 Viagra Tablets Containing Sildenafil
FDA (Drugs) · 2018-02-07
- CriticalFDA Recalls Unapproved Sildenafil Tablets Sold in Asian Food Markets
FDA (Drugs) · 2018-02-07
- SevereUnapproved herbal capsules containing sildenafil recalled by FDA
FDA (Drugs) · 2018-02-07
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- CriticalXZEN GOLD Recalled for Undeclared Erectile Dysfunction Drug Ingredients
FDA (Drugs) · 2014-09-24
- SevereXZONE GOLD recalled for undeclared erectile dysfunction drug ingredients
FDA (Drugs) · 2014-09-24
- SevereMAC DADDY RED Capsules Recalled for Undeclared Drug Ingredients
FDA (Drugs) · 2022-02-23
- CriticalFDA Recalls Blue Male Enhancement Pill for Unapproved Ingredient
FDA (Drugs) · 2013-04-24
- SevereAvaphinal Maximum Male Enhancement Pills Recalled for Undeclared Drug
FDA (Drugs) · 2022-03-23
- CriticalFDA Recalls 7K Capsules Containing Undeclared Sildenafil and Tadalafil
FDA (Drugs) · 2018-06-06